{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:08:45Z","timestamp":1778767725715,"version":"3.51.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["23-25-00412"],"award-info":[{"award-number":["23-25-00412"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11064-024-04268-9","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T06:09:50Z","timestamp":1731737390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute Behavioral and Neurochemical Effects of Sulpiride in Adult Zebrafish"],"prefix":"10.1007","volume":"50","author":[{"given":"David S.","family":"Galstyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey S.","family":"Lebedev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita P.","family":"Ilyin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria S.","family":"Papulova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita I.","family":"Golushko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria V.","family":"Tishkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryna K.","family":"Saklakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniil","family":"Martynov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana O.","family":"Kolesnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis B.","family":"Rosemberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murilo S.","family":"De Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin A.","family":"Demin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan V.","family":"Kalueff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"issue":"10","key":"4268_CR1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13(10):1161\u20131169","journal-title":"Nat Neurosci"},{"key":"4268_CR2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jad.2015.09.005","volume":"189","author":"EI Fried","year":"2016","unstructured":"Fried EI et al (2016) What are\u2019good\u2019depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. J Affect Disord 189:314\u2013320","journal-title":"J Affect Disord"},{"key":"4268_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03392158","volume":"31","author":"JW Kanter","year":"2008","unstructured":"Kanter JW et al (2008) The nature of clinical depression: symptoms, syndromes, and behavior analysis. Behav Analyst 31:1\u201321","journal-title":"Behav Analyst"},{"key":"4268_CR4","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, D. and, American Psychiatric D, Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5, vol 5. American psychiatric association Washington, DC","DOI":"10.1176\/appi.books.9780890425596"},{"key":"4268_CR5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2015.05.053","volume":"321","author":"C M\u00e9nard","year":"2016","unstructured":"M\u00e9nard C, Hodes GE, Russo SJ (2016) Pathogenesis of depression: insights from human and rodent studies. Neuroscience 321:138\u2013162","journal-title":"Neuroscience"},{"key":"4268_CR6","doi-asserted-by":"crossref","first-page":"382604","DOI":"10.3389\/fpsyt.2018.00334","volume":"9","author":"M Shadrina","year":"2018","unstructured":"Shadrina M, Bondarenko EA, Slominsky PA (2018) Genetics factors in major depression disease. Front Psychiatry 9:382604","journal-title":"Front Psychiatry"},{"key":"4268_CR7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.pharep.2014.04.009","volume":"66","author":"E Og\u0142odek","year":"2014","unstructured":"Og\u0142odek E et al (2014) The role of the neuroendocrine and immune systems in the pathogenesis of depression. Pharmacol Rep 66:776\u2013781","journal-title":"Pharmacol Rep"},{"issue":"3","key":"4268_CR8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1037\/a0035302","volume":"140","author":"GM Slavich","year":"2014","unstructured":"Slavich GM, Irwin MR (2014) From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 140(3):774\u2013815","journal-title":"Psychol Bull"},{"issue":"20","key":"4268_CR9","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","volume":"163","author":"MJ Bair","year":"2003","unstructured":"Bair MJ et al (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163(20):2433\u20132445","journal-title":"Arch Intern Med"},{"issue":"6","key":"4268_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0006-3223(02)01472-5","volume":"52","author":"KRR Krishnan","year":"2002","unstructured":"Krishnan KRR et al (2002) Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 52(6):559\u2013588","journal-title":"Biol Psychiatry"},{"issue":"2","key":"4268_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0272-7358(99)00026-4","volume":"20","author":"JD Swendsen","year":"2000","unstructured":"Swendsen JD, Merikangas KR (2000) The comorbidity of depression and substance use disorders. Clin Psychol Rev 20(2):173\u2013189","journal-title":"Clin Psychol Rev"},{"issue":"12","key":"4268_CR12","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1176\/ajp.150.12.1779","volume":"150","author":"A Angold","year":"1993","unstructured":"Angold A, Costello E (1993) Depressive comorbidity in children and adolescents. Am J Psychiatry 150(12):1779\u20131791","journal-title":"Am J Psychiatry"},{"key":"4268_CR13","doi-asserted-by":"crossref","unstructured":"Richards CS, O\u2019Hara MW (2014) The Oxford handbook of depression and comorbidity. Oxford University Press","DOI":"10.1093\/oxfordhb\/9780199797004.001.0001"},{"issue":"1","key":"4268_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","volume":"64","author":"J Per\u00e4l\u00e4","year":"2007","unstructured":"Per\u00e4l\u00e4 J et al (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 64(1):19\u201328","journal-title":"Arch Gen Psychiatry"},{"key":"4268_CR15","unstructured":"Per\u00e4l\u00e4 J (2012) Epidemiology of psychotic disorders."},{"issue":"5","key":"4268_CR16","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S2468-2667(19)30056-8","volume":"4","author":"HE Jongsma","year":"2019","unstructured":"Jongsma HE et al (2019) International incidence of psychotic disorders, 2002\u201317: a systematic review and meta-analysis. Lancet Public Health 4(5):e229\u2013e244","journal-title":"Lancet Public Health"},{"issue":"2","key":"4268_CR17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1037\/0021-843X.100.2.214","volume":"100","author":"P Rohde","year":"1991","unstructured":"Rohde P, Lewinsohn PM, Seeley JR (1991) Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. J Abnorm Psychol 100(2):214","journal-title":"J Abnorm Psychol"},{"key":"4268_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2019.11.035","volume":"216","author":"RS Wilson","year":"2020","unstructured":"Wilson RS, Yung AR, Morrison AP (2020) Comorbidity rates of depression and anxiety in first episode psychosis: a systematic review and meta-analysis. Schizophr Res 216:322\u2013329","journal-title":"Schizophr Res"},{"issue":"4","key":"4268_CR19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/15622970500316674","volume":"6","author":"H-J M\u00f6ller","year":"2005","unstructured":"M\u00f6ller H-J (2005) Occurrence and treatment of depressive comorbidity\/cosyndromality in schizophrenic psychoses: conceptual and treatment issues. World J Biol Psychiatry 6(4):247\u2013263","journal-title":"World J Biol Psychiatry"},{"key":"4268_CR20","doi-asserted-by":"crossref","unstructured":"McCutcheon RA, Marques TR, Howes OD (2020) Schizophrenia\u2014an overview. JAMA Psychiatry 77(2):201\u2013210","DOI":"10.1001\/jamapsychiatry.2019.3360"},{"issue":"9","key":"4268_CR21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.5498\/wjp.v12.i9.1204","volume":"12","author":"S Chakrabarti","year":"2022","unstructured":"Chakrabarti S, Singh N (2022) Psychotic symptoms in bipolar disorder and their impact on the illness: a systematic review. World J Psychiatry 12(9):1204","journal-title":"World J Psychiatry"},{"issue":"1","key":"4268_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Krystal JH, Howes OD (2020) Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry 19(1):15\u201333","journal-title":"World Psychiatry"},{"key":"4268_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10571-006-9062-8","volume":"26","author":"JT Coyle","year":"2006","unstructured":"Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26:363\u2013382","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"4268_CR24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41380-022-01808-z","volume":"28","author":"C-Y Zhang","year":"2023","unstructured":"Zhang C-Y et al (2023) Genetic evidence for the dopamine hypothesis of bipolar disorder. Mol Psychiatry 28(2):532\u2013535","journal-title":"Mol Psychiatry"},{"issue":"8","key":"4268_CR25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","volume":"53","author":"M Fava","year":"2003","unstructured":"Fava M (2003) Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53(8):649\u2013659","journal-title":"Biol Psychiatry"},{"key":"4268_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.1106e16","volume":"67","author":"D Souery","year":"2006","unstructured":"Souery D, Papakostas GI, Trivedi MH (2006) Treatment-resistant depression. J Clin Psychiatry 67:16","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"4268_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4068\/cmj.2018.54.2.101","volume":"54","author":"S-M Wang","year":"2018","unstructured":"Wang S-M et al (2018) Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J 54(2):101","journal-title":"Chonnam Med J"},{"issue":"10","key":"4268_CR28","first-page":"1245","volume":"159","author":"E Trindade","year":"1998","unstructured":"Trindade E et al (1998) Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ 159(10):1245\u20131252","journal-title":"CMAJ"},{"issue":"4","key":"4268_CR29","first-page":"5","volume":"61","author":"GW Arana","year":"2000","unstructured":"Arana GW (2000) An overview of side effects caused by typical antipsychotics. J Clin Psychiatry 61(4):5\u201313","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"4268_CR30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.2051-5545.2008.tb00154.x","volume":"7","author":"A \u00dc\u00e7ok","year":"2008","unstructured":"\u00dc\u00e7ok A, Gaebel W (2008) Side effects of atypical antipsychotics: a brief overview. World Psychiatry 7(1):58\u201362","journal-title":"World Psychiatry"},{"key":"4268_CR31","doi-asserted-by":"crossref","unstructured":"Gardner DM, Teehan MD (2010) Antipsychotics and their side effects.","DOI":"10.1017\/CBO9780511919237"},{"issue":"3","key":"4268_CR32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","volume":"174","author":"OD Howes","year":"2017","unstructured":"Howes OD et al (2017) Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry 174(3):216\u2013229","journal-title":"Am J Psychiatry"},{"issue":"2","key":"4268_CR33","first-page":"2783","volume":"80","author":"JM Kane","year":"2019","unstructured":"Kane JM et al (2019) Clinical guidance on the identification and management of treatment-resistant schizophrenia. J Clin Psychiatry 80(2):2783","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"4268_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1192\/bjp.2019.120","volume":"216","author":"SE Legge","year":"2020","unstructured":"Legge SE et al (2020) Clinical indicators of treatment-resistant psychosis. Br J Psychiatry 216(5):259\u2013266","journal-title":"Br J Psychiatry"},{"key":"4268_CR35","doi-asserted-by":"crossref","first-page":"430990","DOI":"10.3389\/fpsyt.2019.00210","volume":"10","author":"D Polese","year":"2019","unstructured":"Polese D et al (2019) Treatment-resistant to antipsychotics: a resistance to everything? Psychotherapy in treatment-resistant schizophrenia and nonaffective psychosis: a 25-year systematic review and exploratory meta-analysis. Front Psychiatry 10:430990","journal-title":"Front Psychiatry"},{"key":"4268_CR36","unstructured":"Matthysse S (1973) Antipsychotic drug actions: a clue to the neuropathology of schizophrenia."},{"issue":"13","key":"4268_CR37","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1503\/cmaj.1041064","volume":"172","author":"DM Gardner","year":"2005","unstructured":"Gardner DM, Baldessarini RJ, Waraich P (2005) Modern antipsychotic drugs: a critical overview. CMAJ 172(13):1703\u20131711","journal-title":"CMAJ"},{"issue":"1","key":"4268_CR38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuron.2006.09.015","volume":"52","author":"CA Ross","year":"2006","unstructured":"Ross CA et al (2006) Neurobiology of schizophrenia. Neuron 52(1):139\u2013153","journal-title":"Neuron"},{"issue":"7","key":"4268_CR39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.euroneuro.2012.05.012","volume":"23","author":"C Bj\u00f6rkholm","year":"2013","unstructured":"Bj\u00f6rkholm C et al (2013) Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine. Eur Neuropsychopharmacol 23(7):709\u2013720","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"4268_CR40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ajmg.b.30635","volume":"147","author":"A Meary","year":"2008","unstructured":"Meary A et al (2008) Pharmacogenetic study of atypical antipsychotic drug response: involvement of the norepinephrine transporter gene. Am J Med Genet Part B: Neuropsychiatric Genet 147(4):491\u2013494","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"issue":"04","key":"4268_CR41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-979218","volume":"32","author":"E R\u00fcther","year":"1999","unstructured":"R\u00fcther E et al (1999) Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial. Pharmacopsychiatry 32(04):127\u2013135","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"4268_CR42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/106002809502900210","volume":"29","author":"CF Caley","year":"1995","unstructured":"Caley CF, Weber SS (1995) Sulpiride: an antipsychotic with selective dopaminergic antagonist properties. Ann Pharmacother 29(2):152\u2013160","journal-title":"Ann Pharmacother"},{"issue":"2","key":"4268_CR43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0306-4522(96)00307-7","volume":"75","author":"B Ellenbroek","year":"1996","unstructured":"Ellenbroek B, Budde S, Cools A (1996) Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 75(2):535\u2013542","journal-title":"Neuroscience"},{"issue":"7","key":"4268_CR44","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1046\/j.1460-9568.2002.01948.x","volume":"15","author":"BA Ellenbroek","year":"2002","unstructured":"Ellenbroek BA, Lubbers LJ, Cools AR (2002) The role of hippocampal dopamine receptors in prepulse inhibition. Eur J Neurosci 15(7):1237\u20131243","journal-title":"Eur J Neurosci"},{"key":"4268_CR45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF00427417","volume":"83","author":"A Vaccheri","year":"1984","unstructured":"Vaccheri A et al (1984) Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression. Psychopharmacology 83:28\u201333","journal-title":"Psychopharmacology"},{"key":"4268_CR46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02245639","volume":"121","author":"A Vergoni","year":"1995","unstructured":"Vergoni A, Forgione A, Bertolini A (1995) Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of depression-like behavior. Psychopharmacology 121:279\u2013281","journal-title":"Psychopharmacology"},{"issue":"4","key":"4268_CR47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1601-5215.2008.00284.x","volume":"20","author":"C Bell","year":"2008","unstructured":"Bell C et al (2008) The response to sulpiride in major depression before and after cognitive behavioural therapy: D2 receptor function. Acta Neuropsychiatrica 20(4):199\u2013206","journal-title":"Acta Neuropsychiatrica"},{"issue":"4","key":"4268_CR48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/syn.890010408","volume":"1","author":"D Clark","year":"1987","unstructured":"Clark D, White FJ (1987) D1 dopamine receptor\u2014the search for a function: a critical evaluation of the D1\/D2 dopamine receptor classification and its functional implications. Synapse 1(4):347\u2013388","journal-title":"Synapse"},{"key":"4268_CR49","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/00002826-199001001-00009","volume":"13","author":"G Serra","year":"1990","unstructured":"Serra G et al (1990) Possible mechanism of antidepressant effect of L-sulpiride. Clin Neuropharmacol 13:S76\u2013S83","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"4268_CR50","doi-asserted-by":"crossref","first-page":"14289","DOI":"10.1038\/s41598-021-92422-6","volume":"11","author":"KA Demin","year":"2021","unstructured":"Demin KA et al (2021) Modulation of behavioral and neurochemical responses of adult zebrafish by fluoxetine, eicosapentaenoic acid and lipopolysaccharide in the prolonged chronic unpredictable stress model. Sci Rep 11(1):14289","journal-title":"Sci Rep"},{"key":"4268_CR51","doi-asserted-by":"crossref","first-page":"108637","DOI":"10.1016\/j.jneumeth.2020.108637","volume":"337","author":"KA Demin","year":"2020","unstructured":"Demin KA et al (2020) The zebrafish tail immobilization (ZTI) test as a new tool to assess stress-related behavior and a potential screen for drugs affecting despair-like states. J Neurosci Methods 337:108637","journal-title":"J Neurosci Methods"},{"issue":"13","key":"4268_CR52","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1021\/acschemneuro.2c00123","volume":"13","author":"KA Demin","year":"2022","unstructured":"Demin KA et al (2022) Acute behavioral and neurochemical effects of novel n-benzyl-2-phenylethylamine derivatives in adult zebrafish. ACS Chem Neurosci 13(13):1902\u20131922","journal-title":"ACS Chem Neurosci"},{"key":"4268_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ntt.2017.04.002","volume":"62","author":"KA Demin","year":"2017","unstructured":"Demin KA et al (2017) Acute effects of amitriptyline on adult zebrafish: potential relevance to antidepressant drug screening and modeling human toxidromes. Neurotoxicol Teratol 62:27\u20133","journal-title":"Neurotoxicol Teratol"},{"key":"4268_CR54","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11064-018-2536-5","volume":"43","author":"DA Meshalkina","year":"2018","unstructured":"Meshalkina DA et al (2018) The effects of chronic Amitriptyline on zebrafish behavior and monoamine neurochemistry. Neurochem Res 43:1191\u20131199","journal-title":"Neurochem Res"},{"key":"4268_CR55","doi-asserted-by":"crossref","unstructured":"Ilyin NP et al (2024) Chronic behavioral and neurochemical effects of four novel N-Benzyl-2-phenylethylamine derivatives recently identified as psychoactive in adult zebrafish screens. ACS Chemical Neurosci 15(10):2006\u20132017","DOI":"10.1021\/acschemneuro.4c00017"},{"key":"4268_CR56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neubiorev.2019.07.017","volume":"105","author":"KA Demin","year":"2019","unstructured":"Demin KA et al (2019) Developing zebrafish experimental animal models relevant to schizophrenia. Neurosci Biobehavioral Reviews 105:126\u2013133","journal-title":"Neurosci Biobehavioral Reviews"},{"issue":"1","key":"4268_CR57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2010.05.010","volume":"40","author":"P Panula","year":"2010","unstructured":"Panula P et al (2010) The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 40(1):46\u201357","journal-title":"Neurobiol Dis"},{"key":"4268_CR58","first-page":"115","volume":"10","author":"Y Du","year":"2016","unstructured":"Du Y et al (2016) Spatial and temporal distribution of dopaminergic neurons during development in zebrafish. Front Neuroanat 10:115","journal-title":"Front Neuroanat"},{"issue":"5","key":"4268_CR59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/zeb.2015.1106","volume":"12","author":"AM Stewart","year":"2015","unstructured":"Stewart AM et al (2015) Building zebrafish neurobehavioral phenomics: effects of common environmental factors on anxiety and locomotor activity. Zebrafish 12(5):339\u2013348","journal-title":"Zebrafish"},{"issue":"7","key":"4268_CR60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0028-3908(76)90119-2","volume":"15","author":"M Santacana","year":"1976","unstructured":"Santacana M, Sanchez E, Munoz M (1976) Effects of the administration of two doses of sulpiride on the behaviour of the rat. Neuropharmacology 15(7):415\u2013420","journal-title":"Neuropharmacology"},{"key":"4268_CR61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.aquatox.2015.08.007","volume":"170","author":"AV Kalueff","year":"2016","unstructured":"Kalueff AV et al (2016) Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology research. Aquat Toxicol 170:297\u2013309","journal-title":"Aquat Toxicol"},{"key":"4268_CR62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pharep.2013.06.012","volume":"66","author":"P Kulkarni","year":"2014","unstructured":"Kulkarni P et al (2014) Oral dosing in adult zebrafish: proof-of-concept using pharmacokinetics and pharmacological evaluation of carbamazepine. Pharmacol Rep 66:179\u2013183","journal-title":"Pharmacol Rep"},{"key":"4268_CR63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbr.2012.08.041","volume":"236","author":"J Cachat","year":"2013","unstructured":"Cachat J et al (2013) Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research. Behav Brain Res 236:258\u2013269","journal-title":"Behav Brain Res"},{"key":"4268_CR64","doi-asserted-by":"crossref","unstructured":"Wang D et al (2020) Behavioral and physiological effects of acute and chronic kava exposure in adult zebrafish. Neurotoxicol Teratol 79:106881","DOI":"10.1016\/j.ntt.2020.106881"},{"key":"4268_CR65","unstructured":"Serikuly N et al (2020) Effects of acute and chronic arecoline in adult zebrafish: Anxiolytic-like activity, elevated brain monoamines and the potential role of microglia. Prog Neuropsychopharmacol Biol Psychiatry,: p. 1\u201311"},{"key":"4268_CR66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neubiorev.2018.12.025","volume":"99","author":"R Genario","year":"2019","unstructured":"Genario R et al (2019) The evolutionarily conserved role of melatonin in CNS disorders and behavioral regulation: translational lessons from zebrafish. Neurosci Biobehavioral Reviews 99:117\u2013127","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"4268_CR67","doi-asserted-by":"crossref","unstructured":"Meshalkina DA et al (2018) The effects of chronic amitriptyline on zebrafish behavior and Monoamine Neurochemistry. Neurochem Res 43(6):1191\u20131199","DOI":"10.1007\/s11064-018-2536-5"},{"issue":"1","key":"4268_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-75855-3","volume":"10","author":"KA Demin","year":"2020","unstructured":"Demin KA et al (2020) Understanding complex dynamics of behavioral, neurochemical and transcriptomic changes induced by prolonged chronic unpredictable stress in zebrafish. Sci Rep 10(1):1\u201320","journal-title":"Sci Rep"},{"key":"4268_CR69","doi-asserted-by":"crossref","unstructured":"Demin KA et al (2020) Understanding neurobehavioral effects of acute and chronic stress in zebrafish. Stress 24(1):1\u201318","DOI":"10.1080\/10253890.2020.1724948"},{"key":"4268_CR70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbr.2018.10.033","volume":"359","author":"AD Volgin","year":"2019","unstructured":"Volgin AD et al (2019) Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish. Behav Brain Res 359:274\u2013280","journal-title":"Behav Brain Res"},{"issue":"1","key":"4268_CR71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuropharm.2011.07.037","volume":"62","author":"A Stewart","year":"2012","unstructured":"Stewart A et al (2012) Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 62(1):135\u2013143","journal-title":"Neuropharmacology"},{"issue":"10","key":"4268_CR72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/laban.1345","volume":"46","author":"DA Meshalkina","year":"2017","unstructured":"Meshalkina DA et al (2017) Adult zebrafish in CNS disease modeling: a tank that\u2019s half-full, not half-empty, and still filling. Lab Anim 46(10):378\u2013387","journal-title":"Lab Anim"},{"issue":"1","key":"4268_CR73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/zeb.2012.0861","volume":"10","author":"AV Kalueff","year":"2013","unstructured":"Kalueff AV et al (2013) Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 10(1):70\u201386","journal-title":"Zebrafish"},{"issue":"1","key":"4268_CR74","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/mp.2014.128","volume":"20","author":"AM Stewart","year":"2015","unstructured":"Stewart AM et al (2015) Molecular psychiatry of zebrafish. Mol Psychiatry 20(1):2\u201317","journal-title":"Mol Psychiatry"},{"key":"4268_CR75","doi-asserted-by":"crossref","unstructured":"Canzian J et al (2024) The influence of acute dopamine transporter inhibition on manic-, depressive-like phenotypes and brain oxidative status in adult zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 130:110961","DOI":"10.1016\/j.pnpbp.2024.110961"},{"key":"4268_CR76","doi-asserted-by":"crossref","first-page":"113906","DOI":"10.1016\/j.bbr.2022.113906","volume":"430","author":"YM Kositsyn","year":"2022","unstructured":"Kositsyn YM et al (2022) Towards translational modeling of behavioral despair and its treatment in zebrafish. Behav Brain Res 430:113906","journal-title":"Behav Brain Res"},{"issue":"4","key":"4268_CR77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/17460441.2019.1575360","volume":"14","author":"KA Demin","year":"2019","unstructured":"Demin KA et al (2019) Animal models of major depressive disorder and the implications for drug discovery and development. Expert Opin Drug Discov 14(4):365\u2013378","journal-title":"Expert Opin Drug Discov"},{"key":"4268_CR78","doi-asserted-by":"crossref","first-page":"112644","DOI":"10.1016\/j.bbr.2020.112644","volume":"389","author":"L Yang","year":"2020","unstructured":"Yang L et al (2020) Delayed behavioral and genomic responses to acute combined stress in zebrafish, potentially relevant to PTSD and other stress-related disorders: focus on neuroglia, neuroinflammation, apoptosis and epigenetic modulation. Behav Brain Res 389:112644","journal-title":"Behav Brain Res"},{"key":"4268_CR79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainresbull.2020.11.017","volume":"167","author":"TO Kolesnikova","year":"2021","unstructured":"Kolesnikova TO et al (2021) Psychopharmacological characterization of an emerging drug of abuse, a synthetic opioid U-47700, in adult zebrafish. Brain Res Bull 167:48\u201355","journal-title":"Brain Res Bull"},{"key":"4268_CR80","doi-asserted-by":"crossref","first-page":"110405","DOI":"10.1016\/j.pnpbp.2021.110405","volume":"112","author":"DV Bozhko","year":"2022","unstructured":"Bozhko DV et al (2022) Artificial intelligence-driven phenotyping of zebrafish psychoactive drug responses. Prog Neuropsychopharmacol Biol Psychiatry 112:110405","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4268_CR81","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"D Filimonov","year":"2014","unstructured":"Filimonov D et al (2014) Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Compd 50:444\u2013457","journal-title":"Chem Heterocycl Compd"},{"issue":"1","key":"4268_CR82","doi-asserted-by":"crossref","first-page":"17973","DOI":"10.1038\/s41598-022-22169-1","volume":"12","author":"B Zhang","year":"2022","unstructured":"Zhang B et al (2022) Environmentally-relevant concentrations of the antipsychotic drugs sulpiride and clozapine induce abnormal dopamine and serotonin signaling in zebrafish brain. Sci Rep 12(1):17973","journal-title":"Sci Rep"},{"key":"4268_CR83","doi-asserted-by":"crossref","unstructured":"Li F et al (2018) Characterization of the locomotor activities of zebrafish larvae under the influence of various neuroactive drugs. Annals Translational Med 6(10):173","DOI":"10.21037\/atm.2018.04.25"},{"issue":"1","key":"4268_CR84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0091-3057(90)90125-2","volume":"36","author":"J Bruhwyler","year":"1990","unstructured":"Bruhwyler J et al (1990) Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test. Pharmacol Biochem Behav 36(1):57\u201361","journal-title":"Pharmacol Biochem Behav"},{"key":"4268_CR85","first-page":"125","volume":"89","author":"EM Pich","year":"1986","unstructured":"Pich EM, Samanin R (1986) Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine. Psychopharmacology 89:125\u2013130","journal-title":"Psychopharmacology"},{"issue":"2\u20133","key":"4268_CR86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0028-3908(87)90209-7","volume":"26","author":"B Costall","year":"1987","unstructured":"Costall B et al (1987) Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology 26(2\u20133):195\u2013200","journal-title":"Neuropharmacology"},{"issue":"1","key":"4268_CR87","first-page":"15","volume":"63","author":"K Kato","year":"1993","unstructured":"Kato K (1993) Response of patients in mixed state of anxiety and depression to low dose sulpiride. Igaku kenkyu. Acta Med 63(1):15\u201319","journal-title":"Acta Med"},{"issue":"2","key":"4268_CR88","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0269881112450778","volume":"27","author":"C Bell","year":"2013","unstructured":"Bell C et al (2013) The response to sulpiride in social anxiety disorder: D2 receptor function. J Psychopharmacol 27(2):146\u2013151","journal-title":"J Psychopharmacol"},{"key":"4268_CR89","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF00427274","volume":"81","author":"H Standish-Barry","year":"1983","unstructured":"Standish-Barry H et al (1983) A randomized double blind group comparative study of sulpiride and Amitriptyline in affective disorder. Psychopharmacology 81:258\u2013260","journal-title":"Psychopharmacology"},{"issue":"10","key":"4268_CR90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17116\/jnevro201511510162-65","volume":"115","author":"V Vil\u2019yanov","year":"2015","unstructured":"Vil\u2019yanov V, Kremenitskaya S, Solov\u2019eva N (2015) The efficacy of sulpiride in patients with anxiety disorders depending on the serum serotonin concentrations. Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 115(10):62\u201365","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova"},{"issue":"3","key":"4268_CR91","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/schbul\/sbs002","volume":"39","author":"EC-C Lai","year":"2013","unstructured":"Lai EC-C et al (2013) Effectiveness of sulpiride in adult patients with schizophrenia. Schizophr Bull 39(3):673\u2013683","journal-title":"Schizophr Bull"},{"issue":"1","key":"4268_CR92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-2999(98)00796-1","volume":"363","author":"T Nakazato","year":"1998","unstructured":"Nakazato T, Horikawa HP, Akiyama A (1998) The dopamine D2 receptor antagonist sulpiride causes long-lasting serotonin release. Eur J Pharmacol 363(1):29\u201334","journal-title":"Eur J Pharmacol"},{"key":"4268_CR93","doi-asserted-by":"crossref","unstructured":"Bernaerts P, Tirelli E (2003) Facilitatory effect of the dopamine D4 receptor agonist PD168, 077 on memory consolidation of an inhibitory avoidance learned response in C57BL\/6J mice. Behav Brain Res. 142(1\u20132):41\u201352","DOI":"10.1016\/S0166-4328(02)00371-6"},{"issue":"1","key":"4268_CR94","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2005.08.002","volume":"82","author":"KE Browman","year":"2005","unstructured":"Browman KE et al (2005) A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats. Pharmacol Biochem Behav 82(1):148\u2013155","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"4268_CR95","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/FBP.0b013e32831c3b06","volume":"19","author":"ML Woolley","year":"2008","unstructured":"Woolley ML et al (2008) Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat. Behav Pharmacol 19(8):765\u2013776","journal-title":"Behav Pharmacol"},{"issue":"1","key":"4268_CR96","doi-asserted-by":"crossref","first-page":"15693","DOI":"10.1038\/s41598-021-95016-4","volume":"11","author":"A Dahlen","year":"2021","unstructured":"Dahlen A et al (2021) THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior. Sci Rep 11(1):15693","journal-title":"Sci Rep"},{"issue":"1","key":"4268_CR97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2011.05.034","volume":"224","author":"KJ Seibt","year":"2011","unstructured":"Seibt KJ et al (2011) Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio). Behav Brain Res 224(1):135\u2013139","journal-title":"Behav Brain Res"},{"key":"4268_CR98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","volume":"282","author":"CP Ford","year":"2014","unstructured":"Ford CP (2014) The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282:13\u201322","journal-title":"Neuroscience"},{"key":"4268_CR99","doi-asserted-by":"crossref","unstructured":"Wolf ME, Roth RH (1990) Autoreceptor regulation of dopamine synthesis. Annals of the New York Academy of Sciences","DOI":"10.1111\/j.1749-6632.1990.tb32003.x"},{"issue":"26","key":"4268_CR100","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1523\/JNEUROSCI.0918-12.2012","volume":"32","author":"A Anzalone","year":"2012","unstructured":"Anzalone A et al (2012) Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci 32(26):9023\u20139034","journal-title":"J Neurosci"},{"issue":"2","key":"4268_CR101","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1471-4159.1992.tb09391.x","volume":"59","author":"RT Kennedy","year":"1992","unstructured":"Kennedy RT, Jones SR, Wightman RM (1992) Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J Neurochem 59(2):449\u2013455","journal-title":"J Neurochem"},{"issue":"23","key":"4268_CR102","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.21-23-09134.2001","volume":"21","author":"M Benoit-Marand","year":"2001","unstructured":"Benoit-Marand M, Borrelli E, Gonon F (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 21(23):9134\u20139141","journal-title":"J Neurosci"},{"issue":"6","key":"4268_CR103","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/02698811231166463","volume":"37","author":"KN Zabegalov","year":"2023","unstructured":"Zabegalov KN et al (2023) Behavioral profile of adult zebrafish acutely exposed to a selective dopamine uptake inhibitor, GBR 12909. J Psychopharmacol 37(6):601\u2013609","journal-title":"J Psychopharmacol"},{"issue":"1","key":"4268_CR104","first-page":"656370","volume":"2014","author":"N Divac","year":"2014","unstructured":"Divac N et al (2014) Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int 2014(1):656370","journal-title":"Biomed Res Int"},{"issue":"5","key":"4268_CR105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acschemneuro.6b00014","volume":"7","author":"F Ek","year":"2016","unstructured":"Ek F et al (2016) Behavioral analysis of dopaminergic activation in zebrafish and rats reveals similar phenotypes. ACS Chem Neurosci 7(5):633\u2013646","journal-title":"ACS Chem Neurosci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04268-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:05:39Z","timestamp":1738411539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04268-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4268"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04268-9","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were approved by the Institutional IACUC and fully adhered to the National and Institutional guidelines and regulations on animal experimentation, as well as the 3Rs principles of humane animal experimentation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11"}}